share_log

Benchmark Reiterates Buy on Quipt Home Medical, Maintains $10 Price Target

Benzinga ·  Dec 20, 2023 23:48

Benchmark analyst Bill Sutherland reiterates Quipt Home Medical (NASDAQ:QIPT) with a Buy and maintains $10 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment